Targeted News Service logo

-- Preview Email Newsletter
Journals Biology Newsletter for 2026-11-06 ( 6 items )  
GCC researchers awarded $2.8M NIH grant towards pancreatic cancer treatment (10)
AUGUSTA, Georgia, Nov. 5 -- Augusta University posted the following news release: * * * GCC researchers awarded $2.8M NIH grant towards pancreatic cancer treatment * Research that has been a decade in the making for three members of the Georgia Cancer Center may lead to improvements in the current treatment of pancreatic cancer. "We started this research with leukemia cells years ago," said Nahid F. Mivechi, PhD, professor in the Department of Radiation Oncology at the Medical College of Georgia at Augusta University. "It has come quite fa more PR

Johnson & Johnson announces U.S. FDA Approval of RYBREVANT FASPRO as First and Only Dual-Targeted Therapy for Advanced Head and Neck Cancer (10)
RARITAN, New Jersey, Nov. 5 [Category: BizPharmaceuticals] -- Johnson and Johnson Innovative Medicine posted the following news release: * * * Johnson & Johnson announces U.S. FDA Approval of RYBREVANT FASPRO(tm) (amivantamab and hyaluronidase-lpuj) as First and Only Dual-Targeted Therapy for Advanced Head and Neck Cancer * New Brunswick, N.J. (November 5, 2026) - Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for RYBREVANT FASPRO(tm) (amivantamab and hyaluronidase more PR

Johnson & Johnson announces U.S. FDA Approval of RYBREVANT FASPRO(tm) (amivantamab and hyaluronidase-lpuj) as First and Only Dual-Targeted Therapy for Advanced Head and Neck Cancer (10)
NEW BRUNSWICK, New Jersey, Nov. 5 [Category: BizHealth & Beauty] -- Johnson and Johnson posted the following news release: * * * Johnson & Johnson announces U.S. FDA Approval of RYBREVANT FASPRO(tm) (amivantamab and hyaluronidase-lpuj) as First and Only Dual-Targeted Therapy for Advanced Head and Neck Cancer * New Brunswick, N.J. (November 5, 2026) - Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for RYBREVANT FASPRO(tm) (amivantamab and hyaluronidase-lpuj) (subcut more PR

Penn Nursing Professor Co-Authors Landmark First-Ever Lancet Series Dedicated to Men's Health (10)
PHILADELPHIA, Pennsylvania, Nov. 5 -- The University of Pennsylvania School of Nursing issued the following news: * * * Penn Nursing Professor Co-Authors Landmark First-Ever Lancet Series Dedicated to Men's Health Register for the official, virtual November 5 global launch event hosted by the Liverpool School of Tropical Medicine and The Lancet to engage with co-authors and health equity experts. Derek M. Griffith, PhD, the Risa Lavizzo-Mourey Population Health and Health Equity University Professor in Penn Nursing and Penn Medicine, and Di more PR

Prairie to Pharmacy program discovers common coulee plant that may contain key to new medicines (10)
LETHBRIDGE, Alberta, Nov. 5 -- The University of Lethbridge posted the following news: * * * Prairie to Pharmacy program discovers common coulee plant that may contain key to new medicines * Joint study with University of British Columbia lab identifies compounds in the Prairie Crocus that affect cell division One of the most common prairie plants dotting the coulees of southern Alberta may prove to be anything but ordinary thanks to work out of Dr. Roy Golsteyn's lab and the Prairie to Pharmacy program at the University of Lethbridge. Ut more PR

University of Miami: Nearly Half of the World's Coral Species Now Face Extinction Risk (10)
CORAL GABLES, Florida, Nov. 6 -- The University of Miami issued the following news: * * * Nearly half of the world's coral species now face extinction risk A new study involving a University of Miami researcher finds that warming oceans and marine heatwaves are accelerating threats to coral reefs worldwide. By Robert C. Jones Jr. rcjones@miami.edu 11-04-2026 From the Great Barrier Reef and the Coral Triangle to the Mesoamerican Barrier Reef System and the Red Sea, nearly half of the world's reef-building coral species face an elevated risk more PR